Literature DB >> 15763349

Highly sensitive hepatitis C virus RNA detection assays for decision of treatment (dis)continuation in patients with chronic hepatitis C.

Ulrike Mihm, Wolf-Peter Hofmann, Bernd Kronenberger, Michael von Wagner, Stefan Zeuzem, Christoph Sarrazin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15763349     DOI： 10.1016/j.jhep.2004.08.026

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  3 in total

Review 1.  Current therapy for hepatitis C.

Authors:  Mireen Friedrich-Rust; Stefan Zeuzem; Christoph Sarrazin
Journal:  Int J Colorectal Dis       Date:  2005-09-21       Impact factor: 2.571

2.  Prognostic significance of hepatitis C virus RNA detection by transcription-mediated amplification with negative polymerase chain reaction during therapy with peginterferon alpha and ribavirin.

Authors:  Jaydeep S Kadam; Stevan A Gonzalez; Furqaan Ahmed; Alia Menezes; Ira M Jacobson
Journal:  Dig Dis Sci       Date:  2007-04-04       Impact factor: 3.199

3.  Differences between two real-time PCR-based hepatitis C virus (HCV) assays (RealTime HCV and Cobas AmpliPrep/Cobas TaqMan) and one signal amplification assay (Versant HCV RNA 3.0) for RNA detection and quantification.

Authors:  Johannes Vermehren; Annika Kau; Barbara C Gärtner; Reinhild Göbel; Stefan Zeuzem; Christoph Sarrazin
Journal:  J Clin Microbiol       Date:  2008-09-17       Impact factor: 5.948
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.